Black Diamond Therapeutics is a next-wave cancer precision medicine company. Black Diamond pioneered the development of selective medicines for patients with genetically defined cancers driven by oncogenes activated by allosteric mutations. Using its mutation, allostery and pharmacology (MAP) computational and discovery platform, Black Diamond is uncovering new ways to functionally assess the mutational landscape of individual oncogenes – to discover and validate new targets and develop novel approaches to creating highly selective therapeutics.
Black Diamond has an exciting opening for an experienced cancer biologist to serve as Director – Discovery Biology at the research site located in New York City. Reporting to the VP of Discovery Biology, the incumbent will lead a biology team and drive drug discovery projects through close collaboration with others to reshape and extend the pipeline of precision oncology medicines.